SCHEMBL10748921

SCHEMBL10748921

O=[N+]([O-])c1ccc2[se]n(-c3ncccn3)c(=S)c2c1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.37
▸ GAA P10253 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MPI P34949 1/20 0.37
▸ APOBEC3G Q9HC16 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ PARP1 P09874 1/20 0.35
▸ GPR35 Q9HC97 1/20 0.35
▸ IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502370 0.86 KMT2A (0.42) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL10748866 0.85 L3MBTL1 (0.43) MAPTGAANPSR1MEN1KMT2A
SCHEMBL10502345 0.81 ALDH1A1 (0.50) MAPTNPSR1MEN1KMT2AALDH1A1
SCHEMBL10501717 0.80 LMNA (0.35) MAPTGAANPSR1MEN1KMT2A
SCHEMBL10747422 0.77 MEN1 (0.41) MAPTNPSR1MEN1KMT2AALDH1A1
SCHEMBL5916533 0.77 KMT2A (0.45) MAPTGAAMEN1KMT2AALDH1A1
SCHEMBL10747582 0.74 METAP2 (0.40) MAPTNPSR1MEN1KMT2AALDH1A1
SCHEMBL10746433 0.73 KMT2A (0.38) MAPTMEN1KMT2AALDH1A1MPI
SCHEMBL10746666 0.71 MAPT (0.45) MAPTMEN1KMT2AALDH1A1MPI
SCHEMBL10501715 0.70 MEN1 (0.46) MAPTNPSR1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback